Novartis NVS and AbbVie ABBV announced small M&A deals. The FDA approved the expanded use of Pfizer’s PFE cancer drug ...

Bambusa Therapeutics has raised about $90 million to build out a pipeline of next-gen bispecific antibodies targeting ...

Pharmaceutical companies make drugs and vaccines from chemical bases. Below, we’ll look at the growth opportunities with Canada’s top pharmaceutical stocks and see if they’re right for you.

Adding around $1.5 billion in annual sales by 2030 would be a step in the right direction for Vertex Pharmaceuticals but this wouldn't be a transformative contribution. In November, the company ...

An ammonia gas leak at a pharmaceutical company in Padra taluka of Vadodara district late on Friday evening killed one person and left four others unconscious, police said Saturday. The incident ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

And STAT is a media company ... Boston Globe Media. These two organizations aggregate and publish some of the most reliable numbers to help answer these questions. A 2020 STAT analysis found more than ...

And STAT is a media company started by Boston Globe Media ... found more than two-thirds of Congress receiving a check from pharmaceutical companies that year. More recent data from Open Secrets ...

With this core understanding of key suppliers' activity, Pharmaceutical companies could then map their supply chains, to find out exactly who is supplying products through all the many tiers.

Most of these innovations have been done by smaller companies, and R&D efforts by the biggest pharmaceutical companies have often been not very successful. Nevertheless, the pharmaceutical industry is ...

Sun Pharma's Q3FY25 net profit rose 15% YoY to ₹2,903 crore, driven by strong domestic and global specialty sales. Revenue grew 10.5%, while EBITDA surged 15.3% with improved margins. The company ...

Federal officials approved a new non-opioid painkiller developed by a Boston pharmaceutical company on Thursday, calling it a “first-in-class” treatment that avoids the addictive risks of ...